Found 12 matching trials
Testosterone and Alendronate in Hypogonadal Men
PHASE2This study will investigate the hypothesis that the combination of testoste...
Location
Massachusetts General Hospital
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
PHASE4The aim of the study is to assess the relative antiresorptive properties of...
Location
Massachusetts General Hospital
Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes
N/ACompare the data obtained with two formulations of alendronate 70 mg (table...
Location
Endokrinologische Praxis & Labor
Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis
NAThis study investigates the use of blood tests known as Bone Turnover Marke...
Location
Northwest General Hospital
Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.
PHASE2Aortic stenosis is a condition whereby one of the heart valves (aortic valv...
Location
Clinical Research Facility University of Edinburgh
Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation
N/ADiscontinuation of denosumab results in a rebound response of bone turnover...
Location
251 Hellenic Air Force & VA General Hospital
Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.
PHASE1The objective of this study is to compare the rate and extent of absorption...
Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss
PHASE4Antiretroviral therapy (ART) initiation is associated with a significant lo...
Location
Mater Misericordiae University Hospital
Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment
PHASE3The purpose of this study is to evaluate the use of an oral bisphosphonate ...
Location
Sydney South West Area Health Service
Phase IV Clinical Trial to Evaluate Efficacy and Safety of MASI BONE S (Alendronate Sodium Trihydrate) in Postmenopausal Women With Osteoporosis
PHASE4This study aims to prove non-inferiority of the efficacy of Masibone S (ale...
Location
Yonsei University Health System, Severance Hospital